QuickEM
For emergency medicine clinicians, including medical students, residents, and attending physicians.
QuickEM is an established medical app that is a paid app. With a 4.6/5 rating from 10 reviews, it shows polarized user reception.
What is QuickEM?
QuickEM is a specialized emergency medicine reference app for clinicians, featuring clinical calculators and protocols in a one-time purchase format.
Clinicians hire QuickEM for rapid, offline access to ED-specific decision tools, avoiding the bloat and subscription costs of generalist medical platforms.
Current Momentum
v7.2 · today
Intense- Added dark mode by user request.
- Ships periodic bug fix releases.
Active Nemesis
MDCalc Medical Calculator
By MD Aware
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalRating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Over 80 chief complaint topics including differentials, history, tests, and treatments for ED-specific care
Over 90 validated medical calculators and scoring systems grouped by clinical category
Full content availability without internet connectivity
How much does it cost?
- Single purchase at $4.99
Paid model targets professionals who prioritize a one-time cost for reliable, offline tools without recurring subscription friction.
Who Built It?
Portfolio
3
Apps
What other apps does Dirkes Medical, PLLC make?
Reductinn -Tinnitus Relief CBT
QuickAcuity
Explore the full Dirkes Medical, PLLC report
Portfolio breakdown, audience, momentum, and every app published by Dirkes Medical, PLLC.
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for QuickEM?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
QuickEM maintains a presence in the US Medical category, though its grossing rank frequently lags behind its paid rank. This gap signals that the current pricing model captures initial interest but lacks long-term monetisation depth.
Rank progression
32 active rankings tracked — 30-day window
The rivals identified
Nemeses(1)
Dominates the clinical decision support niche with massive scale and high-frequency usage, serving as the primary bedside reference for the same audience as QuickEM.
Differentiators
- Provides a massive library of peer-reviewed clinical calculators that integrate directly into clinical workflows.
- Maintains a high-trust brand position through rigorous editorial oversight of every medical algorithm included.
- Offers a highly optimized mobile-first interface that prioritizes rapid data entry for time-pressured clinicians.
Head to head
QuickEM must double down on its emergency-specific workflow efficiency to defend against MDCalc's broader, more established utility.
Contenders(3)
Combines a professional network with clinical tools, creating a powerful social and utility-based moat.
Differentiators
- Facilitates secure physician-to-physician communication and networking, which is a unique utility not found in reference apps.
- Provides a robust directory of clinicians and healthcare facilities that serves as a primary professional resource.
The gold standard for evidence-based clinical decision support, representing the highest barrier to entry in the space.
Differentiators
- Provides deep, evidence-based clinical summaries that are considered the industry standard for bedside decision support.
- Maintains a subscription-based model that is often institutionalized, creating significant friction for users to switch apps.
A massive, multi-functional platform that captures the majority of the medical reference market share.
Differentiators
- Integrates comprehensive drug reference databases alongside clinical news and continuing medical education modules.
- Operates as a massive content ecosystem that keeps users within the app for news and research.
Same space(3)
Specializes in diagnostic support through visual imagery, serving an adjacent need in the emergency department.
Differentiators
- Utilizes a vast library of clinical images to assist in the diagnosis of dermatological and systemic conditions.
- Provides a unique visual-first search experience that is highly effective for identifying rashes and lesions.
A legacy medical reference tool that provides high-quality, trusted clinical content for professionals.
Differentiators
- Delivers authoritative, peer-reviewed medical content that is free from the influence of commercial advertising.
- Focuses on deep clinical knowledge rather than the quick-reference calculator tools found in QuickEM.
A direct competitor in the clinical calculator space, though it lacks the specific emergency medicine focus of the target.
Differentiators
- Features a highly intuitive interface that simplifies complex clinical scoring systems for rapid bedside use.
- Offers seamless integration with institutional subscriptions to provide full-text article access for users.
New entrants(1)
An emerging platform that uses crowdsourced medical cases to drive engagement and clinical learning.
Differentiators
- Leverages a social-first approach to medical education by allowing clinicians to share and discuss real-world cases.
- Builds community engagement through interactive case studies that provide a more dynamic learning experience than static references.
Compare QuickEM against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for QuickEM
Strengths to defend, gaps to attack
Core Strengths
- ED-specific workflow focus reduces cognitive load during high-pressure shifts.
- Offline-first architecture ensures reliability in hospital zones with poor connectivity.
Critical Frictions
- Single-purchase model limits recurring revenue for high-velocity clinical content updates.
- Lack of Android-specific rating data suggests a potential visibility gap.
Growth Levers
- Develop B2B partnerships with residency programs to establish the app as a standard training tool.
Market Threats
- MDCalc's high-velocity update cycle risks rendering QuickEM's clinical content obsolete.
What are the next best moves?
Pivot to a freemium model because the current $4.99 cap limits R&D budget → increase recurring revenue.
Grossing rank lags behind paid rank, indicating a failure to capture long-term value from the user base.
Trade-off: Pause the development of new calculator tools — existing library is sufficient for current retention.
Audit Android store presence because rating data is missing → improve discoverability.
Android platform data shows null ratings and version info, suggesting a potential breakdown in store visibility.
Trade-off: Deprioritize iOS feature updates for one cycle — Android visibility is a higher-risk gap.
A counter-intuitive read
QuickEM's lack of a subscription model is a competitive weakness, yet it remains the primary moat against institutional-heavy rivals like UpToDate that force users into high-friction enterprise contracts.
Feature Gaps vs Competitors
- Integrated drug reference databases (available in Medscape but absent here)
- Full-text article access (available in Calculate by QxMD but absent here)
Key Takeaways
QuickEM wins on bedside speed and offline reliability, but its single-purchase model limits the R&D budget needed to compete with MDCalc's update cadence, so the PM should pivot to freemium to capture long-term value.
Where Is It Heading?
Mixed Signals
The medical reference market is consolidating around high-velocity, multi-specialty platforms that leverage subscription revenue to fund constant content updates. QuickEM remains exposed due to its static revenue model, which limits its ability to defend against MDCalc's rapid clinical updates and erode the user base.
The lack of Android-specific rating data suggests a visibility gap that prevents the app from scaling beyond its current iOS-heavy user base.
Recent updates focused on stability and dark mode, indicating the app is currently in maintenance mode rather than aggressive feature expansion.